|
 |
|
2022 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities
This new 97-country report from VPGMarketResearch.com is available by geographic region, country, market segment, section, or individual test....
|
 |
|
$34500.00 |
| |
|
|
|
2022 Europe Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities
This new 38-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test....
|
|
|
$24500.00 |
| |
|
|
|
2022 Cancer Diagnostics: A Market on the Verge of Explosion--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence
VPGMarketResearch introduces a new study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines trends in the U....
|
|
|
$9500.00 |
| |
|
|
|
2022 Latin America Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities
This new 22-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test....
|
|
|
$9500.00 |
| |
|
|
|
2022 Asia-Pacific Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities
This new 17-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test....
|
|
|
$8500.00 |
| |
|
|
|
2022 Competing in the European Cancer Diagnostics Market:
France, Germany, Italy, Spain, UK
This new five-country report from Venture Planning Group identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends in France, Germany, Italy, Spain, and the UK; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.
|
|
|
$7500.00 |
| |
|
|
|
Analysis of the Global Cancer Diagnostics Market: Emerging Tests, Technology Assessment, Instrumentation Review, Sales Forecasts by Country and Strategic Profiles of Leading Suppliers
This new report from Venture Planning Group provides analysis of the global cancer diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers.The report presents: Estimated numbers of cancer testing laboratories, as well as test volume and sales forecasts for France, Germany, Italy, Japan, Spain, U....
|
|
|
$7500.00 |
| |
|
|
|
Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country
This unique report from VPGMarketResearch.com provides sales and market share estimates for major suppliers of cancer diagnostic testing products by assay and country....
|
|
|
$7200.00 |
| |
|
|
|
2022 North America Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities
This new 3-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test....
|
|
|
$6900.00 |
| |
|
|
|
2022 Middle East Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities
This new 11-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test....
|
|
|
$6500.00 |
| |
|
|
|
Europe Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country
This unique report from Venture Planning Group provides Europe sales and market share estimates for major suppliers of cancer diagnostic testing products by assay and country.The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
|
|
|
$6000.00 |
| |
|
|
|
Innovative CA Tumor Marker Testing Technologies and Emerging Markets
This report presents a detailed analysis of the CA 15-3/27.29, CA 19-9, and CA 125 testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5- and 10-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers.
|
|
|
$4850.00 |
| |
|
|
|
US Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country
This unique report from Venture Planning Group provides US sales and market share estimates for major suppliers of cancer diagnostic testing products by assay and country.The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
|
|
|
$4000.00 |
| |
|
|
|
Innovative CEA Testing Technologies and Emerging Markets
This report presents a detailed analysis of the CEA testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5- and 10-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers.
|
|
|
$3850.00 |
| |
|
|
|
Innovative AFP Testing Technologies and Emerging Markets
This report presents a detailed analysis of the Alpha-fetoprotein testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5- and 10-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers.
|
|
|
$3850.00 |
| |
|
|
|
Innovative Beta-2 Microglobulin Testing Technologies and Emerging Markets
This report presents a detailed analysis of the Beta-2 Microglobulin testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5- and 10-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers.
|
|
|
$3850.00 |
| |
|
|
|
Innovative Occult Blood Testing Technologies and Emerging Markets
This report presents a detailed analysis of the Occult Blood testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5- and 10-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers.
|
|
|
$3850.00 |
| |
|
|
|
Innovative Prostatic Acid Phosphatase Testing Technologies
And Emerging Markets
This report presents a detailed analysis of the PAP testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5- and 10-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers.
|
|
|
$3850.00 |
| |
|
|
|
|